Suppr超能文献

血清骨硬化蛋白水平随季节变化。

Serum sclerostin levels vary with season.

机构信息

Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging (B.D.-H., S.S.H., L.C., N.J.P.), Tufts University, and Division of Endocrinology, Diabetes, and Metabolism (B.D.-H., L.C.), Tufts Medical Center, Boston, Massachusetts 02111.

出版信息

J Clin Endocrinol Metab. 2014 Jan;99(1):E149-52. doi: 10.1210/jc.2013-3148. Epub 2013 Dec 20.

Abstract

CONTEXT

To establish the clinical utility of serum sclerostin levels, it is important to know whether there is seasonal variation in the measurements.

OBJECTIVE

This study was done to determine whether serum sclerostin levels vary by season in healthy older men and women.

METHODS

Serum sclerostin levels were measured in archived serum of 314 healthy men and women aged 65 years and older and examined for seasonal variation. Several factors known to vary by season and previously reported to be associated with serum sclerostin levels, including serum osteocalcin, physical activity, and serum PTH levels, were also measured in these subjects. Sex did not modify the association of season with sclerostin, so the men and women were analyzed together.

RESULTS

Serum sclerostin levels varied significantly by season (P < .001, after adjustment for sex). Sclerostin levels in the wintertime were 20% higher than the all-year mean, the levels gradually declined through the spring and summer, and by the fall, they were 20% below the all-year mean. Adjustment for serum osteocalcin, physical activity, and serum PTH did not alter the seasonal means. Seasonal differences in serum osteocalcin, physical activity, and serum PTH were not statistically significant.

CONCLUSIONS

This study documents marked seasonal variation in serum sclerostin levels. It is important to recognize this source of biological variability when considering the potential clinical utility of sclerostin measurements.

摘要

背景

为了确定血清骨硬化蛋白水平的临床实用性,了解其测量值是否存在季节性变化非常重要。

目的

本研究旨在确定健康老年男女的血清骨硬化蛋白水平是否存在季节性变化。

方法

检测了 314 名年龄在 65 岁及以上的健康男女的存档血清中的血清骨硬化蛋白水平,并检查了其季节性变化。还测量了这些受试者中已知随季节变化且先前与血清骨硬化蛋白水平相关的几个因素,包括血清骨钙素、身体活动和血清甲状旁腺激素水平。性别并未改变季节与骨硬化蛋白之间的关联,因此将男性和女性一起进行分析。

结果

血清骨硬化蛋白水平随季节显著变化(P<0.001,调整性别后)。冬季的骨硬化蛋白水平比全年平均值高 20%,春季和夏季逐渐下降,到秋季时比全年平均值低 20%。调整血清骨钙素、身体活动和血清甲状旁腺激素水平后,季节性平均值并未改变。血清骨钙素、身体活动和血清甲状旁腺激素的季节性差异无统计学意义。

结论

本研究记录了血清骨硬化蛋白水平的显著季节性变化。在考虑骨硬化蛋白测量值的潜在临床实用性时,必须认识到这种生物变异性的来源。

相似文献

1
Serum sclerostin levels vary with season.
J Clin Endocrinol Metab. 2014 Jan;99(1):E149-52. doi: 10.1210/jc.2013-3148. Epub 2013 Dec 20.
2
Acute decline in serum sclerostin in response to PTH infusion in healthy men.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1848-51. doi: 10.1210/jc.2011-1534. Epub 2011 Aug 24.
3
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
J Clin Endocrinol Metab. 2010 Nov;95(11):5056-62. doi: 10.1210/jc.2010-0720. Epub 2010 Jul 14.
6
Serum sclerostin levels in healthy men over 50 years of age.
J Bone Miner Metab. 2013 Sep;31(5):579-84. doi: 10.1007/s00774-013-0451-z. Epub 2013 Mar 24.
7
Serum sclerostin increases in healthy adult men during bed rest.
J Clin Endocrinol Metab. 2012 Sep;97(9):E1736-40. doi: 10.1210/jc.2012-1579. Epub 2012 Jul 5.
9
Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
J Clin Endocrinol Metab. 2010 Apr;95(4):1991-7. doi: 10.1210/jc.2009-2283. Epub 2010 Feb 15.
10
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
J Clin Endocrinol Metab. 2012 Jan;97(1):148-54. doi: 10.1210/jc.2011-2152. Epub 2011 Oct 12.

引用本文的文献

1
An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients.
Indian J Hematol Blood Transfus. 2025 Apr;41(2):306-314. doi: 10.1007/s12288-024-01864-1. Epub 2024 Sep 12.
2
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder.
Clin Kidney J. 2024 Jun 20;17(7):sfae188. doi: 10.1093/ckj/sfae188. eCollection 2024 Jul.
3
Serum sclerostin levels as a diagnostic marker for osteoporosis.
Bioinformation. 2024 Jan 31;20(1):54. doi: 10.6026/973206300200054. eCollection 2024.
5
The effect of regular fitness training, sex hormones, and turnover of selected bone markers on sclerostin levels in young women.
Arch Med Sci. 2020 Oct 3;19(3):586-592. doi: 10.5114/aoms.2020.99624. eCollection 2023.
7
Serum sclerostin levels in osteoporotic fracture patients.
Eur J Trauma Emerg Surg. 2022 Dec;48(6):4857-4865. doi: 10.1007/s00068-022-02017-7. Epub 2022 Jun 16.
9
Romosozumab: a novel bone anabolic treatment option for osteoporosis?
Wien Med Wochenschr. 2020 Apr;170(5-6):124-131. doi: 10.1007/s10354-019-00721-5. Epub 2019 Dec 19.

本文引用的文献

3
Serum sclerostin and risk of hip fracture in older Caucasian women.
J Clin Endocrinol Metab. 2012 Jun;97(6):2027-32. doi: 10.1210/jc.2011-3419. Epub 2012 Mar 30.
4
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
J Clin Endocrinol Metab. 2012 May;97(5):1737-44. doi: 10.1210/jc.2011-2958. Epub 2012 Mar 7.
5
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
J Clin Endocrinol Metab. 2012 Jan;97(1):234-41. doi: 10.1210/jc.2011-2186. Epub 2011 Oct 26.
7
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
J Clin Endocrinol Metab. 2010 Nov;95(11):5056-62. doi: 10.1210/jc.2010-0720. Epub 2010 Jul 14.
8
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
J Clin Endocrinol Metab. 2010 May;95(5):2248-53. doi: 10.1210/jc.2010-0067. Epub 2010 Mar 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验